Modafinil
C1538D/312/AD/US
Phase 3 small_molecule completed
Quick answer
Modafinil for Attention Deficit/Hyperactivity Disorder is a Phase 3 program (small_molecule) at Teva Pharma GmbH with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Attention Deficit/Hyperactivity Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed